What You Should Know:
GYANT announced that Intermountain Healthcare is leveraging its COVID-19 Screener and Emergency Response Assistant to support patients during this frightening and uncertain time.
GYANT’s COVID-19 assistant is allowing Intermountain Healthcare to screen patients for symptoms and risk factors, as many people aren’t sure if they should be tested for the COVID-19 virus.
Based on the patients’ responses, the assistant directs patients to the most appropriate level of medical care, helping keep patients in their homes. Intermountain has seen over 125,000 users engage with the tool since deployment, with a 93% screening completion rate.
Intermountain Healthcare and GYANT, a patient connection and relationship management company, today announced that it is now deploying a jointly developed COVID-19 Screener and Emergency Response Assistant (COVID-19 SERA), created in collaboration with Intermountain infectious disease clinicians. The automated chat solution, available via Intermountain Healthcare’s homepage, offers screening and care navigation support for all Intermountain Healthcare patients, and answers questions related to symptoms and prevention.
COVID-19 SERA Overview
With the COVID-19 SERA, Intermountain patients now have access to the most current information about the spread of COVID-19 from the Centers for Disease Control and Prevention (CDC) and Intermountain infectious disease clinicians. The solution screens for COVID-19 symptoms and risk factors, and based on patients’ responses, directs them to the most appropriate medical settings. It is also equipped with tips and recommendations to help educate patients and prevent further spread of COVID-19. Intermountain is delivering all of this information via a highly customized version of GYANT’s COVID-19 SERA, branded as ‘Scout.’
COVID-19 SERA Deployment Results to Date
Since the deployment of COVID-19 SERA, Intermountain has seen more than 157,000 users in 2.5 weeks, with an average of about 9,300 per day. The tool has conducted COVID-19 screenings for Intermountain patients with a 93% screening completion rate. Intermountain has also seen a 30% decrease in call center volume, which helps alleviate strain on the call center and opens up lines of patient-clinician communications for those who need it most.
“At Intermountain, we’re committed to keeping our patients informed and giving them access to the tools and support they need during this critical time,” said Kevan Mabbutt, Intermountain Healthcare’s chief consumer officer. “That’s why we worked with GYANT to develop ‘Scout,’ a friendly virtual assistant that provides on-demand screening and answers to our community’s COVID-19-related questions. ‘Scout’ is especially important with COVID-19 because it helps people get symptoms checked out quickly and easily while social distancing at home and prioritizes testing and telehealth resources for those who need them most.”
